Form 8-K - Current report:
SEC Accession No. 0001213900-14-006918
Filing Date
2014-09-25
Accepted
2014-09-25 17:28:05
Documents
27
Period of Report
2014-09-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k092514_actinium.htm 8-K 23298
2 ACTINIUM PHARMACEUTICALS, INC., CORPORATE PRESENTATION. f8k092514ex99i_actinium.htm EX-99.1 20667
3 GRAPHIC page_1.jpg GRAPHIC 49850
4 GRAPHIC page_2.jpg GRAPHIC 527016
5 GRAPHIC page_3.jpg GRAPHIC 166884
6 GRAPHIC page_4.jpg GRAPHIC 286835
7 GRAPHIC page_5.jpg GRAPHIC 416115
8 GRAPHIC page_6.jpg GRAPHIC 419392
9 GRAPHIC page_7.jpg GRAPHIC 302207
10 GRAPHIC page_8.jpg GRAPHIC 250963
11 GRAPHIC page_9.jpg GRAPHIC 253759
12 GRAPHIC page_10.jpg GRAPHIC 306943
13 GRAPHIC page_11.jpg GRAPHIC 215126
14 GRAPHIC page_12.jpg GRAPHIC 296740
15 GRAPHIC page_13.jpg GRAPHIC 302184
16 GRAPHIC page_14.jpg GRAPHIC 377616
17 GRAPHIC page_15.jpg GRAPHIC 340666
18 GRAPHIC page_16.jpg GRAPHIC 197878
19 GRAPHIC page_17.jpg GRAPHIC 250765
20 GRAPHIC page_18.jpg GRAPHIC 300948
21 GRAPHIC page_19.jpg GRAPHIC 303931
22 GRAPHIC page_20.jpg GRAPHIC 312622
23 GRAPHIC page_21.jpg GRAPHIC 352656
24 GRAPHIC page_22.jpg GRAPHIC 430062
25 GRAPHIC page_23.jpg GRAPHIC 212321
26 GRAPHIC page_24.jpg GRAPHIC 267598
27 GRAPHIC page_25.jpg GRAPHIC 136252
  Complete submission text file 0001213900-14-006918.txt   10075132
Mailing Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 5TH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36374 | Film No.: 141121404
SIC: 2834 Pharmaceutical Preparations